Sexual Health & Medical Wellness Johns Hopkins researchers develop innovative intranasal DNA vaccine to combat drug-tolerant tuberculosis October 26, 2026 Susilo Ahmad Tuberculosis (TB) remains a formidable global health crisis, persisting for over six millennia as a leading cause of mortality from a single infectious pathogen. Despite significant medical advancements, the bacterium…
Sexual Health & Medical Wellness Johns Hopkins Researchers Develop Novel Intranasal DNA Vaccine to Combat Drug-Tolerant Tuberculosis Persisters October 14, 2026 Susilo Ahmad Researchers at Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health have unveiled a pioneering experimental therapeutic DNA vaccine designed to target the persistent, drug-tolerant bacteria responsible…
Sexual Health & Medical Wellness Johns Hopkins researchers develop innovative intranasal DNA vaccine to combat drug-tolerant tuberculosis bacteria October 7, 2026 Susilo Ahmad A collaborative team of scientists from Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health has unveiled a novel therapeutic DNA vaccine candidate designed to revolutionize the…
Sexual Health & Medical Wellness Johns Hopkins Researchers Develop Novel Intranasal DNA Vaccine to Combat Drug-Tolerant Tuberculosis Persisters September 28, 2026 Susilo Ahmad Tuberculosis remains a formidable global health crisis, persisting as one of the deadliest infectious diseases in human history despite six millennia of coexistence with our species. A team of researchers…
Sexual Health & Medical Wellness Breakthrough Intranasal DNA Vaccine Offers New Hope for Eradicating Drug-Tolerant Tuberculosis Persisters September 12, 2026 Susilo Ahmad Researchers at Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health have unveiled a pioneering experimental therapeutic DNA vaccine that could fundamentally shift the paradigm of tuberculosis…
Sexual Health & Medical Wellness Johns Hopkins Researchers Develop Experimental Intranasal DNA Vaccine Targeting Drug-Tolerant Tuberculosis Bacteria July 19, 2026 Susilo Ahmad Researchers at Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health have unveiled a groundbreaking experimental therapeutic DNA vaccine for tuberculosis (TB), delivered non-invasively through the nose.…
Sexual Health & Medical Wellness Johns Hopkins Researchers Develop Novel Intranasal DNA Vaccine Targeting Drug-Tolerant Tuberculosis July 12, 2026 Susilo Ahmad Researchers at Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health have achieved a significant breakthrough in the fight against tuberculosis (TB), developing an experimental therapeutic DNA…
Sexual Health & Medical Wellness Novel Intranasal Vaccine Shows Promise Against H5N1 Avian Influenza, Offering Enhanced Pandemic Preparedness July 9, 2026 Susilo Ahmad The development of an innovative intranasal vaccine against H5N1 avian influenza by researchers at Washington University School of Medicine in St. Louis marks a significant advancement in the global effort…
Sexual Health & Medical Wellness Johns Hopkins Researchers Develop Novel Intranasal DNA Vaccine Targeting Drug-Tolerant TB Bacteria, Offering New Hope Against Global Health Scourge. July 5, 2026 Susilo Ahmad Researchers at Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health have achieved a significant breakthrough in the fight against tuberculosis (TB), developing an experimental therapeutic DNA…
Sexual Health & Medical Wellness Washington University Researchers Pioneer Novel Intranasal Vaccine Offering Enhanced Protection Against Evolving H5N1 Avian Influenza Threat. July 2, 2026 Susilo Ahmad The escalating global concern over the H5N1 avian influenza virus, commonly known as bird flu, has been met with a significant scientific breakthrough from researchers at Washington University School of…
